Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)
Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –
Nephros free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nephros's free cash flow for the twelve months ending Dec 31, 2024 was -$547.00K. For fiscal 2024 it was -$547.00K, down 172.7% from the year before. The highest annual figure on record is $752.00K in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$547.00K | -172.7% |
| FY2023 | Dec 31, 2023 | $752.00K | – |
| FY2022 | Dec 31, 2022 | -$3.37M | – |
| FY2021 | Dec 31, 2021 | -$1.45M | – |
| FY2020 | Dec 31, 2020 | -$7.14M | – |
| FY2019 | Dec 31, 2019 | -$2.29M | – |
| FY2016 | Dec 31, 2016 | -$2.16M | – |
| FY2015 | Dec 31, 2015 | -$3.83M | – |
| FY2013 | Dec 31, 2013 | -$3.58M | – |
| FY2012 | Dec 31, 2012 | -$1.56M | – |
| FY2010 | Dec 31, 2010 | -$1.32M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $1.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$623.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$195.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$170.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$335.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$923.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$117.00K | -132.1% |
| Q1 FY2021 | Mar 31, 2021 | -$78.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.83M | – |
| Q4 FY2019 | Dec 31, 2019 | $364.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$528.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$795.00K | – |
See a number that looks wrong?